Cannapharmarx Inc
(CPMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,340 | -5,741 | -4,215 | -20,451 | -11,137 |
| Depreciation Amortization | 1,804 | 1,072 | 666 | 4,564 | 3,165 |
| Accounts receivable | N/A | N/A | N/A | -500 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 226 | 47 |
| Other Working Capital | 2,799 | 2,329 | 2,051 | -1,515 | -1,245 |
| Other Operating Activity | 2,905 | 1,666 | 1,132 | 13,882 | 6,350 |
| Operating Cash Flow | $-832 | $-673 | $-366 | $-3,795 | $-2,821 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -5 | -3 |
| Purchase Sale Intangibles | 96 | 62 | -2 | N/A | 0 |
| Other Investing Activity | 96 | 62 | -2 | -42 | -37 |
| Investing Cash Flow | $96 | $62 | $-2 | $-47 | $-39 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 930 | 534 | 438 | 1,550 | 1,275 |
| Debt Issued | -4 | -87 | -95 | 1,340 | 1,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -99 | -99 |
| Other Financing Activity | 0 | 0 | 0 | 475 | 475 |
| Financing Cash Flow | $926 | $447 | $343 | $3,266 | $2,651 |
| Exchange Rate Effect | 52 | 166 | 106 | 113 | -62 |
| Beginning Cash Position | 2 | 2 | 2 | 464 | 464 |
| End Cash Position | 243 | 4 | 83 | 2 | 193 |
| Net Cash Flow | $242 | $2 | $82 | $-463 | $-272 |
| Free Cash Flow | |||||
| Operating Cash Flow | -832 | -673 | -366 | -3,795 | -2,821 |
| Capital Expenditure | N/A | N/A | N/A | -5 | -3 |
| Free Cash Flow | -832 | -673 | -366 | -3,800 | -2,824 |